Bas van Buijtenen
Directeur Général chez LTS LOHMANN Therapie-Systeme AG
Profil
Bas van Buijtenen is currently the Chairman & Chief Executive Officer at LTS LOHMANN.
Therapie-Systeme AG since 2020.
He is also the Business Unit Director at DSM Special Products BV since 2006.
Additionally, he holds the position of Director at Micron Biomedical, Inc. Mr. van Buijtenen previously worked as a Director at Microphyt SA.
Postes actifs de Bas van Buijtenen
| Sociétés | Poste | Début |
|---|---|---|
DSM Special Products BV
 DSM Special Products BV Chemicals: Major DiversifiedProcess Industries DSM Special Products BV specializes in providing toluene oxidation technology. The company uses technologies for the production of benzoic acid (Purox B) and sodium benzoate (Purox S). Its products are used in a range of applications, such as food, carbonated soft drinks, animal feed, plasticisers, resins, personal care, flavours, and fragrances. The firm was founded in 2004 and is headquartered in Rotterdam, the Netherlands. | Corporate Officer/Principal | 01/01/2006 |
LTS LOHMANN Therapie-Systeme AG
 LTS LOHMANN Therapie-Systeme AG Pharmaceuticals: MajorHealth Technology LTS LOHMANN Therapie-Systeme AG manufactures transdermal therapeutic systems and oral thin films. The firm's product range encompasses oral active ingredient films, nicotine patches, and pharmaceutical drugs in dosage forms. Its service areas cover clinical trials, laboratory testing, and research and development projects. The company was founded in 1984 and is headquartered in Andernach, Germany. | Directeur Général | 01/06/2020 |
Micron Biomedical, Inc.
 Micron Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Micron Biomedical, Inc. develops pharmaceutical products. It provides protective (vaccine) and therapeutic (drugs) effects, superior patient compliance, and simplified administration, distribution and storage logistics. The company was founded by Mark Prausnitz, Devin McAllister and Sebastien Henry and is headquartered in Atlanta, GA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Bas van Buijtenen
| Sociétés | Poste | Fin |
|---|---|---|
Microphyt SA
 Microphyt SA BiotechnologyHealth Technology Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
DSM Special Products BV
DSM Special Products BV Chemicals: Major DiversifiedProcess Industries DSM Special Products BV specializes in providing toluene oxidation technology. The company uses technologies for the production of benzoic acid (Purox B) and sodium benzoate (Purox S). Its products are used in a range of applications, such as food, carbonated soft drinks, animal feed, plasticisers, resins, personal care, flavours, and fragrances. The firm was founded in 2004 and is headquartered in Rotterdam, the Netherlands. | Process Industries |
LTS LOHMANN Therapie-Systeme AG
LTS LOHMANN Therapie-Systeme AG Pharmaceuticals: MajorHealth Technology LTS LOHMANN Therapie-Systeme AG manufactures transdermal therapeutic systems and oral thin films. The firm's product range encompasses oral active ingredient films, nicotine patches, and pharmaceutical drugs in dosage forms. Its service areas cover clinical trials, laboratory testing, and research and development projects. The company was founded in 1984 and is headquartered in Andernach, Germany. | Health Technology |
Microphyt SA
Microphyt SA BiotechnologyHealth Technology Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France. | Health Technology |
Micron Biomedical, Inc.
Micron Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Micron Biomedical, Inc. develops pharmaceutical products. It provides protective (vaccine) and therapeutic (drugs) effects, superior patient compliance, and simplified administration, distribution and storage logistics. The company was founded by Mark Prausnitz, Devin McAllister and Sebastien Henry and is headquartered in Atlanta, GA. | Health Technology |
